Skip to main content
Top

01-01-2015 | Gout | Book Chapter | Article

68. Gout

Author: Michael J. Klein, MD

Publisher: Springer London

Abstract

Gout is a metabolic disorder secondary to hyperuricemia in which crystals of monosodium urate cause an acute inflammatory response in joints or a foreign body response in the soft tissues or bones. The most common site is the metacarpophalangeal joint of the great toe and the knee. Soft tissue deposits of urate crystals, tophi, occur. It may present clinically with acute onset of severe pain of a joint or as a chronic joint problem. In bones, radiographs may be normal and later present periarticular erosions. With polarized light, the urate crystals in tophi or synovial fluid appear anisotropic. Prognosis in treated disease is generally good. Uricosuric drugs and allopurinol are used for treatment.
Literature
Bakshi NA, Al-Zaharani H. Bone marrow oxalosis. Blood. 2012;120(1):8.CrossRefPubMed
Desmond P, Hennessy O. Skeletal abnormalities in primary oxalosis. Australas Radiol. 1993;37(1):83–5.CrossRefPubMed
Dieppe P, Swan A. Identification of crystals in synovial fluid. Ann Rheum Dis. 1999;58:261–3.CrossRefPubMedCentralPubMed
Freemont A. Joint diseases. In: Non-neoplastic diseases of bones and joints (Atlas of non-tumor pathology, Fascicle 9). Silver Spring: ARP Press; 2011.
Girish G, Melville DM, Kaeley GS, et al. Imaging appearances in gout. Arthritis. 2013;2012:673401.
Hamburger M, Baraf H, Adamson TC, et al. Recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med. 2011;123(6 suppl 1):3–36.CrossRefPubMed
Harrold L. New developments in gout. Curr Opin Rheumatol. 2013;25(3):304–9.CrossRefPubMed
Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout. Hum Pathol. 1995;26(6):587–93.CrossRefPubMed
Lioté F, Ea HK. Recent developments in crystal induced inflammation pathogenesis and management. Curr Rheumatol Replace. 2007;9:243–50.CrossRef
Reginato AM, Olsen BR. Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear? Curr Opin Rheumatol. 2007;19:134–5.CrossRefPubMed
Richman KM, Boutin RD, Vaughan LM. Tophaceous pseudogout of the sternoclavicular joint. Am J Roentgenol. 1999;172(6):1587–9.CrossRef
Rosenthal AK. Update in calcium deposition diseases. Curr Opin Rheumatol. 2007;19:158–62.CrossRefPubMed
Schlesinger N, Moore DF, Sun JD, Schumacher Jr HR. A survey of current evaluation and treatment of gout. J Rheumatol. 2006;33(10):2050–2.PubMed
Yamakawa K, Iwasaki H, Ohjimi Y, et al. Tumoral calcium pyrophosphate dihydrate crystal deposition disease. A clinicopathologic analysis of five cases. Pathol Res Pract. 2001;197(7):499–506.PubMed